Journal of Rheumatic Diseases

Table. 1.

The demographic characteristics of the study population

Variable Total population (n=107)
Sex, male 88 (82.2)
Age (yr) 35.81±11.78
BMI (kg/m2) 24.66±4.09
ESR (mm/hr) 17.94±17.83
CRP (mg/dL) 0.32±0.77
HLA B27, positive 92 (86.0)
Disease duration (mo) 71.92±71.73
TNF-α inhibitor use 76 (71.0)
Pain (VAS) (cm) 2.48±1.84
Total BASDAI 3.10±1.68
Fatigue 5.28±2.37
Total back pain 3.44±2.37
Peripheral pain/swelling 2.30±2.21
Enthesitis 1.55±2.10
Level of morning stiffness 3.29±2.52
Duration of morning stiffness 2.55±2.36
ASDAS
Total back pain 3.44±2.37
Duration of morning stiffness 2.55±2.36
Patient global assessment 3.10±1.94
Peripheral pain/swelling 2.30±2.21
Total ASDAS-ESR 2.11±0.88
Total ASDAS-CRP 1.83±0.74
ISI 8.42±5.49
ESS 6.50±3.88
PSQI 7.00±3.25
Subjective sleep quality 1.51±0.65
Sleep latency 1.50±1.05
Sleep duration 0.91±0.96
Habitual sleep efficiency 0.33±0.74
Sleep disturbance 1.17±0.50
Use of sleeping medicine 0.17±0.61
Daytime dysfunction 1.43±0.93
BDI-II 11.63±8.05

All values are numbers (%) or means±standard deviations. ASDAS: ankylosing spondylitis disease activity score, BASDAI: bath ankylosing spondylitis disease activity index, BDI: Beck Depression Inventory, BMI: body mass index, CRP: C-reactive protein, ESR: erythrocyte sedimentation rate, ESS: Epworth Sleepiness Scale, HLA B27: Human Leucocyte Antigen B27, ISI: insomnia severity index, PSQI: Pittsburgh Sleep Quality Index, TNF-α: tumor necrosis factor-alpha, VAS: Visual Analogue Scale.

J Rheum Dis 2021;28:143~149 https://doi.org/10.4078/jrd.2021.28.3.143
© J Rheum Dis